Results 151 to 160 of about 107,687,715 (215)

Association Between Serum Syndecan 1 Levels and Metabolic Syndrome Parameters: A Comparative Cross-Sectional Study. [PDF]

Endocrinol Diabetes Metab
Tavalaie S, Darroudi S, Shabani N, AzadAra A, Mottaghi-Moghaddam A, Rahmani MK, Mohammadi-Bajgiran M, Ferns GA, Saberi-Karimian M, Ghayour-Mobarhan M.   +9 more
europepmc   +1 more source

Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer. [PDF]

Cell Rep Med
Yang Z, Theardy MS, Chen S, Wei Y, Takeda M, Zeng Y, Wang X, Yao J, Li J, Thirasastr P, Park J, Zheng Y, Vien LT, Wani KM, Wang H, Gao S, Heffernan T, Kwong L, Wistuba II, Bover L, Draetta GF, Ying H, Yao W.   +22 more
europepmc   +1 more source

Intestinal epithelial Syndecan-1 maintains mucosal homeostasis in inflammatory bowel disease by enhancing <i>Faecalibacterium prausnitzii</i> biofilm formation. [PDF]

Gut Microbes
Chen S, Feng H, Wang Y, Huang J, Xu S, Gong Y, Liu X, Ouyang Y, Ye Q, Zheng D, Sun K, Wang A, Chen Y.   +12 more
europepmc   +1 more source

Targeting Prostate Cancer Cells Using Anti-Sortilin and Anti-Syndecan-1 Antibody Drug Conjugates. [PDF]

Int J Mol Sci
Li KL, Hickey SM, Albrecht H, Logan JM, Lazniewska J, Moore CR, Brooks RD, Johnson IRD, O'Leary JJ, Brooks DA.   +9 more
europepmc   +1 more source

Combined plasma syndecan-1 and renal resistive index as early predictors of sepsis-associated Acute kidney injury: a prospective observational study. [PDF]

Ren Fail
Zhang R, Zhang D, Huang L, Huang X.
europepmc   +1 more source

Prognostic impact of syndecan-1 expression and serum concentration in colorectal cancer. [PDF]

Oncol Lett
Tawada K, Hayashi H, Endo M, Horaguchi T, Yokoi R, Matsumoto K, Kuno M, Fukada M, Asai R, Sato Y, Yasufuku I, Tajima JY, Tanaka Y, Takahashi T, Matsuhashi N, Tomita H.   +15 more
europepmc   +1 more source

Methamphetamine-Induced Loss of Syndecan-1 and Retinal Endothelial Integrity via the TAAR-1/MMP-9 Pathway. [PDF]

Pathophysiology
Lee M, Ha T, Alvarez IA, Leskova W, Park C, Harris NR.   +5 more
europepmc   +1 more source

Ivermectin Attenuates Methotrexate-Induced Liver Fibrosis by Reducing TGF-β and Syndecan-1 Expression. [PDF]

Medicina (Kaunas)
Dibekoğlu C, Kemertaş K, Aygun H, Erbaş O.   +3 more
europepmc   +1 more source

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers. [PDF]

Cell Rep Med
Theardy MS, Takeda M, Sorokin A, Chen S, Yang Z, Wang X, Kanikarla P, Coker O, Nguyen P, Wei Y, Yao J, Yan L, Jin Y, Cai Y, Paku M, Chen Z, Li KZ, Citron F, Tomihara H, Gao S, Deem AK, Zhao J, Wang H, Hanash S, DePinho RA, Maitra A, Draetta GF, Ying H, Kopetz S, Yao W.   +29 more
europepmc   +1 more source

Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. [PDF]

Rheumatology (Oxford)
Carnazzo V, Gulli F, Basile V, Di Santo R, Niccolini B, Redi S, Vinante I, Napodano C, Pocino K, Rapaccini GL, Lizzio MM, Marino M, Ciasca G, Basile U.   +13 more
europepmc   +1 more source